Design of Inhibitory Peptides of the Interaction between the E2 Protein of the Hepatitis C Virus and the CD81 and CD209 receptors
Infection through the Hepatitis C virus does not have a vaccine and treatment with pegylated interferon and ribavirin can fail; which is why it may cause chronic infection and, consequently, could develop liver failure or hepatocellular carcinoma. It has been described that virus-cell recognition oc...
Saved in:
Main Author: | Carlos Andrés Rodríguez-Salazar (Author) |
---|---|
Format: | Book |
Published: |
Asociación Colombiana de Infectología,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Polymer Particles Bearing Recombinant LEL CD81 as Trapping Systems for Hepatitis C Virus
by: Dmitry Polyakov, et al.
Published: (2021) -
The Correlation of CD206, CD209, and Disease Severity in Behçet's Disease with Arthritis
by: Bunsoon Choi, et al.
Published: (2017) -
Dermal-type macrophages expressing CD209/DC-SIGN show inherent resistance to dengue virus growth.
by: Wing-Hong Kwan, et al.
Published: (2008) -
CD81 marks immature and dedifferentiated pancreatic β-cells
by: Ciro Salinno, et al.
Published: (2021) -
<it>CD209 </it>in inflammatory bowel disease: a case-control study in the Spanish population
by: Urcelay Elena, et al.
Published: (2007)